Dynamic changes of the luminal and mucosaassociated gut microbiota during and after antibiotic therapy with paromomycin

Gut Microbes

Volumn 6, Issue 4, 2015, Pages 243-254

  Heinsen, Femke Anouska ^a   Knecht, Henrik ^a   Neulinger, Sven C ^a   Schmitz, Ruth A ^a   Knecht, Carolin ^a   Kühbacher, Tanja ^a,b   Rosenstiel, Philip C ^a,b   Schreiber, Stefan ^a,b   Friedrichs, Anette K ^a,b   Ott, Stephan J ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

16S rRNA gene; Antibiotics; Lumen; Microbiota; Mucosa

Indexed keywords

PAROMOMYCIN; ANTIINFECTIVE AGENT; RIBOSOME DNA; RNA 16S;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIACEAE; CLOSTRIDIUM; ENTEROBACTERIACEAE; ERYSIPELOTRICHACEAE; FEMALE; HUMAN; INTESTINE FLORA; LACHNOSPIRACEAE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PYROSEQUENCING; RNA GENE; RUMINOCOCCACEAE; STREPTOCOCCACEAE; YOUNG ADULT; BACTERIUM; BIOPSY; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; FECES; GENETICS; INTESTINE MUCOSA; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIA; BIOPSY; DNA, RIBOSOMAL; FECES; GASTROINTESTINAL MICROBIOME; HEALTHY VOLUNTEERS; HUMANS; INTESTINAL MUCOSA; MOLECULAR SEQUENCE DATA; PAROMOMYCIN; PHYLOGENY; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 84944454548     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2015.1062959     Document Type: Article

References (62)

1. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-8; PMID:11352068
2. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 1998; 95:6578-83; PMID:9618454
3. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine Science 2005; 307:1915-20; PMID:15790844
4. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora Science 2005; 308:1635-8; PMID:15831718
5. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136:65-80; PMID:19026645
6. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694-7; PMID:19892944
7. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol. 1998; 64:3336-45; PMID:9726880
8. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. A core gut microbiome in obese and lean twins. Nature 2009; 457:480-4; PMID:19043404
9. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans AD, de Vos WM. Mucosaassociated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002; 68:3401-7; PMID:12089021
10. Sullivan A, Endlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1:101-14; PMID:11871461
11. Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 2010; 5:e9836; PMID:20352091
12. Löfmark S, Jernberg C, Jansson JK, Edlund C. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. J Antimicrob Chemother 2006; 58:1160-7; PMID:17046967
13. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Sci U S A 2011; 15:4554-61; PMID:20847294
14. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008; 6:e280; PMID:19018661
15. Jernberg C, Löfmark S, Edlund C, Jansson JK. Longterm ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007; 1:56-66; PMID:18043614
16. Robinson CJ, Young VB. Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes 2010; 1:279-84; PMID:20953272; http://dx.doi.org/10.4161/gmic.1.4.12614
17. Ott SJ, Musfeldt M, Timmis KN, Hampe J, Wenderoth DF, Schreiber S. In vitro alterations of intestinal bacterial microbiota in fecal samples during storage. Diagn Microbiol Infect Dis 2004; 50:237-45; PMID:15582296; http://dx.doi.org/10.1016/j. diagmicrobio.2004.08.012
18. Rehman A, Lepage P, Nolte A, Hellmig S, Schreiber S, Ott SJ, Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 2010; 59:1114-22; PMID:20522625; http://dx.doi.org/10.1099/ jmm.0.021170-0
19. Peris-Bondia F, Latorre A, Artacho A, Moya A, D'Auria G. The active human gut microbiota differs from the total microbiota. PLoS One 2011; 6:e22448; PMID:21829462; http://dx.doi.org/10.1371/journal. pone.0022448
20. Blazewicz SJ, Barnard RL, Daly RA, Firestone MK. Evaluating rRNA as an indicator of microbial activity in environmental communities: limitations and uses. ISME J. 2013; 7:2061-8; PMID:23823491; http://dx. doi.org/10.1038/ismej.2013.102
21. Jost L. Partitioning diversity into independent alpha and beta components. Ecology 2007; 88:2427-39; PMID:18027744; http://dx.doi.org/10.1890/06-1736.1
22. Ott SJ, Plamondon S, Hart A, Begun A, Rehman A, Kamm MA, Schreiber S. Dynamics of the mucosa-associated flora in ulcerative colitis patients during remission and clinical relapse. J Clin Microbiol 2008; 46:3510-3; PMID:18701655; http://dx.doi.org/ 10.1128/JCM.01512-08
23. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Fölsch UR, Timmis KN, Schreiber S. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004; 53:685-93; PMID:15082587; http://dx.doi.org/10.1136/gut.2003.025403
24. Sokol H, Lepage P, Seksik P, Doré J, Marteau P. Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis. J Clin Microbiol 2006; 44:3172-7; PMID:16954244; http://dx.doi.org/ 10.1128/JCM.02600-05
25. Sánchez E, Donat E, Ribes-Koninckx, C, Calabuig M, Sanz Y. Intestinal Bacteroides species associated with coeliac disease. J Clin Pathol 2010; 63:1105-11; PMID:20972239; http://dx.doi.org/10.1136/ jcp.2010.076950
26. Gustafsson RJ, Ohlsson B, Benoni C, Jeppsson B, Olsson C. Mucosa-associated bacteria in two middle-aged women diagnosed with collagenous colitis. World J Gastroenterol 2012; 18:1628-34; PMID:22529692; http://dx.doi.org/10.3748/wjg.v18.i14.1628
27. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47:241-59; PMID:16299351; http://dx.doi.org/ 10.1194/jlr.R500013-JLR200
28. Wells JE, Hylemon PB. Identification and characterization of a bile acid 7 a-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7 adehydroxylating strain isolated from human feces. Appl Environ Microbiol. 2000; 66:1107-13; PMID:10698778; http://dx.doi.org/10.1128/ AEM.66.3.1107-1113.2000
29. Archer IM, Harper PS, Wusteman FS. Multiple forms of iduronate 2-sulphate sulphatase in human tissues and body fluids. Biochim Biophys Acta 1982; 708:134-40; PMID:6816283; http://dx.doi.org/10.1016/0167-4838(82)90213-8
30. Hirano S, Masuda N, Oda H, Imamura T. Transformation of bile acids by mixed microbial cultures from human feces and bile acid transforming activities of isolated bacterial strains. Microbiol Immunol 1981; 25:271-82; PMID:7253965; http://dx.doi.org/ 10.1111/j.1348-0421.1981.tb00029.x
31. Baptissart M, Vega A, Maqdasy S, Caira F, Baron S, Lobaccaro JM, Volle DH. Bile acids: From digestion to cancers. Biochimie 2012; 95(3):504-17; PMID:22766017.; http://dx.doi.org/10.1016/j. biochi.2012.06.022
32. Degirolamo C, Modica S, Palasciano G, Moschetta A. Bile acids and colon cancer: Solving the puzzle with nuclear receptors. Trends Mol Med 2011; 17:564-72; PMID:21724466; http://dx.doi.org/10.1016/j. molmed.2011.05.010
33. Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis. 2009; 15:1183-9; PMID:19235886; http://dx.doi.org/10.1002/ ibd.20903
34. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42:1203-6; PMID:15004076; http://dx.doi.org/ 10.1128/JCM.42.3.1203-1206.2004
35. Fujimoto T, Imaeda H, Takahashi K, Kasumi E, Bamba S, Fujiyama Y, Andoh A. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol 2012; 28 (4):613-9; PMID:23216550.
36. Duboc H, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, Sokol H, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2012; 24:513-20; PMID:22356587; http://dx.doi.org/ 10.1111/j.1365-2982.2012.01893.x
37. Jia W, Whitehead RN, Griffiths L, Dawson C, Waring RH, Ramsden DB, Hunter JO, Cole JA. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol Lett 2010; 310:138-44; PMID:20695899; http://dx.doi.org/10.1111/ j.1574-6968.2010.02057.x
38. Card T. Antibiotic use and the development of Crohn's disease. Gut 2004; 53:246-50; PMID:14724158; http://dx.doi.org/10.1136/gut.2003.025239
39. Kitahara M, Takamine F, Imamura T, Benno Y. Clostridium hiranonis sp. nov., a human intestinal bacterium with bile acid 7a-dehydroxylating activity. Int J Syst Evol Microbiol 2001; 51:39-44; PMID:11211270
40. Navaneethan U, Venkatesh PG, Shen B. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship. World J Gastroenterol 2010; 16:4892-904; PMID:20954275; http://dx.doi.org/10.3748/wjg.v16.i39.4892
41. Dawson LF, Valiente E, Wren BW. Clostridium difficile-a continually evolving and problematic pathogen. Infect Genet Evol 2009; 9:1410-7; PMID:19539054; http://dx.doi.org/10.1016/j.meegid.2009.06.005
42. Pérez-Cobas AE, Gosalbes MJ, Friedrich A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013; 62:1591-601; PMID:23236009; http://dx.doi. org/10.1136/gutjnl-2012-303184
43. Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Monteith P, Noble NA, Sikaroodi M, Gillevet PM. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303: G675-85; PMID:22821944; http://dx.doi.org/ 10.1152/ajpgi.00152.2012
44. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 2012; 7: e39743; PMID:22761885; http://dx.doi.org/10.1371/ journal.pone.0039743
45. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007; 133:24-33; PMID:17631127; http://dx.doi.org/10.1053/j. gastro.2007.04.005
46. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, Jovov B, Abdo Z, Sandler RS, Keku TO. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010; 1:138-47; PMID:20740058; http://dx. doi.org/10.4161/gmic.1.3.12360
47. Rehman A, Sina C, Gavrilova O, Häsler R, Ott S, Baines JF, Schreiber S, Rosenstiel P. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60:1354-62; PMID: 21421666; http://dx.doi.org/10.1136/gut.2010. 216259
48. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009; 75:7537-41; PMID:19801464; http://dx.doi.org/ 10.1128/AEM.01541-09
49. Stratil SB, Neulinger SC, Knecht H, Friedrichs AK, Wahl M. Temperature-driven shifts in the epibiotic bacterial community composition of the brown macroalga Fucus vesiculosus. Microbiologyopen n/a-n/a 2013; 2(2):338-49; PMID:23568841; http://dx.doi. org/10.1002/mbo3.79
50. R core team. R: A language and environment for statistical computing. http://www.r-project.org/ 2012
51. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Stat Methodol 1995; 57:289-300
52. Pinheiro JC, Bates DM, DebRoy S, Sarkar D, R Core Team. nlme: Linear and nonlinear mixed effects models 2014
53. Zuur AF, Ieno EN, Walker NJ, Saveliev AA, Smith GM. Mixed effects models and extensions in ecology with R. Stat. Biol. Heal. Springer 2009
54. Maj A. lmmfit: Goodness-of-fit-measures for linear mixed models with one-level-grouping. http://cran.rproject. org/packageDlmmfit 2011
55. Ludwig W, Schleifer KH, Whitman WB in Bergey's Man. Syst. Bacteriol 2009; 1-13 Springer
56. Borcard D, Legendre P, Gillet F. Numerical ecology with R. 2011
57. Oksanen J, Kindt R, Blanchet FG, Legendre P, Minchin PR, O'Hara RB, Simpson GL, Solymos P, Stevens MHH, Wagner H. vegan: Community ecology package. R package version 2.1-20; http://CRAN.R-project. org/package=vegan 2012
58. Legendre P, Gallagher E. Ecologically meaningful transformations for ordination of species data. Oecologia 2001; 129:271-80; http://dx.doi.org/10.1007/ s004420100716
59. Richardson DC, Richardson JS. The kinemage: A tool for scientific communication. Protein Sci 1992; 1:3-9; PMID:1304880; http://dx.doi.org/10.1002/ pro.5560010102
60. Chen VB, Davis IW, Richardson DC. KING (Kinemage, Next Generation): a versatile interactive molecular and scientific visualization program. Protein Sci 2009; 18:2403-9; PMID:19768809; http://dx.doi.org/ 10.1002/pro.250
61. Zhu M, Ghodsi Ali. Automatic dimensionality selection from the scree plot via the use of profile likelihood. Comput. Stat. Data Anal 2006; 51:918-30;; http://dx. doi.org/10.1016/j.csda.2005.09.010
62. De Cáceres M, Legendre P. Associations between species and groups of sites: indices and statistical inference. Ecology 2009; 90:3566-74; PMID:20120823; http:// dx.doi.org/10.1890/08-1823.1